Clarivate Life Sciences & Healthcare segment acquired by Altaris LLC
Altaris LLC agreed to acquire Clarivate Life Sciences & Healthcare segment, a life sciences information services brand, on Jul 6, 2026.
Transaction summary
- Target
- Clarivate Life Sciences & Healthcare segment
- Acquirer
- Altaris LLC
- Seller
- Clarivate
- Announced
- 2026-07-06
- Geography
- -
- Tags
- HealthcareHealthcare Data And AnalyticsInformation ServicesLife SciencesLife Sciences Information Services
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-08-08
- Latest update
- 2026-08-08
Value and multiples
100% enterprise value
USD 600M
100% enterprise value | USD
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Amounts paid and other reported values
Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.
Consideration: USD 600M
The supplied PR Newswire/Google News headline states that Clarivate announced the segment's sale for $600 million. The available evidence does not specify whether this is enterprise value or equity value.
Basis
- USD 600m consideration is treated as publicly disclosed or derived directly from public source data.
- Valuation covers 100% of the target; the amount invested or paid for a stake is separate.
Source summary
Clarivate Announces Sale of Life Sciences & Healthcare Segment for $600 Million - PR Newswire
ConfirmedClarivate announced an agreement to sell its Life Sciences & Healthcare segment to an affiliate of Altaris LLC for $600 million. The announcement and transaction terms are also disclosed in Clarivate’s SEC Form 8-K.
Open source